Document is current
Any future updates will be listed below
-
Authors
Zheng, Jin-ping
Ling, Yun
Jiang, Liang-shuang
Mootsikapun, Piroon
Lu, Hong-zhou
Chayakulkeeree, Methee
Zhang, Li-xiu
Arttawejkul, Pureepat
Hu, Feng-yu
Truong, Thi Ngoc Lan
Perez, Roxan A.
Gu, Xing
Sun, Hui-min
Jiang, Jian-jie
Liu, Ren-jie
Ding, Zhen
Zhan, Yang-qing
Yang, Zi-feng
Guan, Wei-jie
Zhong, Nan-shan
-
Clinical Trials BETA
Clinical trials referenced in this document:
chictr2200056727 at Chinese Clinical Trial RegistryDocuments that mention this clinical trial
Effects of Lianhuaqingwen Capsules in adults with mild-to-moderate coronavirus disease 2019: an international, multicenter, double-blind, randomized controlled trial
https://doi.org/10.1186/s12985-023-02144-6
-
Funding
Funding for this research was provided by:
Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine (No: ZYYCXTD-D-202206)
the Science and Technology Program of Hebei (225A2503D)
- License Information
-
More Information
Article History
Received: 31 May 2023
Accepted: 26 July 2023
First Online: 28 November 2023
Declarations
:
: Ethics approval has been obtained the ethics committee of each participating site, based on <i>Good Clinical Practice</i>. All patients signed written informed consent.
: None.
